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Abstract
Background: Preliminary evidence suggests an association between obesity and gut inflammation.
Aims: To evaluate the frequency of glucose abnormalities and their correlation with systemic and intestinal
inflammation in severely obese children.
Patients and Methods: Thirty-four children (25 males; median age 10.8 ± 3.4 yrs) with severe obesity (BMI >95%)
were screened for diabetes with oral glucose tolerance test (OGTT), systemic inflammation with C-reactive protein
(CRP) and gut inflammation with rectal nitric oxide (NO) and faecal calprotectin.
Results: BMI ranged from 23 to 44 kg/m
2, and BMI z-score between 2.08 e 4.93 (median 2.69 ± 0.53). Glucose
abnormalities were documented in 71% of patients: type 2 diabetes in 29%, impaired fasting glucose (IFG) in 58%,
and impaired glucose tolerance (IGT) in 37.5%. Thirty-one patients (91%) were hyperinsulinemic. CRP was increased
in 73.5% with a correlation between BMI z-score and CRP (p 0.03). Faecal calprotectin was increased in 47%
patients (mean 77 ± 68), and in 50% of children with abnormal glucose metabolism (mean 76 ± 68 μg/g), with a
correlation with increasing BMI z-score. NO was pathological in 88%, and in 87.5% of glucose impairment (mean
6.8 ± 5 μM).
Conclusions: In this study, the prevalence of glucose abnormalities in obese children is higher than in other series;
furthermore, a correlation is present between markers of systemic and intestinal inflammation and glucose
abnormalities.
Introduction
The global escalation of childhood obesity is a major
concern, as excessive adiposity is believed to be the root
cause of leading metabolic and cardiovascular diseases
and related mortality. Widely prevalent in obese adults,
obesity-related co-morbidities are beginning to surface
in obese children as well [1,2], and we can expect a dra-
matic increase in adolescents and young adults afflicted
with glucose intolerance, hypertension, dyslipidemia,
non-alcoholic fatty liver disease (NAFLD) and ischemic
heart disease and cancer in the very near future [3,4].
T h ep r e v a l e n c eo ft h em e t a bolic syndrome increases
with the severity of obesity and reaches 50% in severely
obese youngsters [2]. Each half-unit increase in the body
mass index, converted to a z score, is associated with an
increase in the risk of the metabolic syndrome among
overweight and obese subjects [5]. Mounting evidence
suggests that insulin resistance resulting from obesity is
pivotal to the pathogenesis of these metabolic conse-
quences [6,7].
Obesity is associated with a chronic low-grade inflam-
mation [6-9] and inflammatory pathways could be critical
in the mechanisms underlying obesity and its complica-
tions, although the factors triggering the inflammatory
response are not known, especially in humans [9]. The
inflammatory process originates and resides mainly in
adipose tissue, which produces cytokines as leptin and
adiponectin [10,11]. This mechanism leads to reduction
of adiponectin levels with increasing obesity, and to
increase of C-reactive protein (CRP) and systemic inflam-
mation [11,12]. Recent epidemiological studies have
s h o w na na s s o c i a t i o nb e t w e en obesity and functional
bowel disorders [6,13,14], possibly as a consequence of
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described correlation exists between obesity and colo-
rectal cancer (CRC) [6].
Intestinal inflammation is relatively rare in children
compared to adults and the spectrum of aetiology is
limited in childhood. We evaluated in a population of
severely obese children the evidence and the degree of
intestinal inflammation judged by non invasive tests. We
also investigated the relationship between intestinal
inflammation and glucose abnormalities.
Patients and methods
Severely obese children (BMI >95% for age and sex,
CDC), non compliant to the dietary regimen, were
recruited at Department of Paediatrics, University of
Naples Federico II, from January 1st 2004 to December
31st 2004.
The pubertal development stages were clinically
assessed by the criteria of Marshall and Tanner [16]
according to pubic hair and breast or genital develop-
ment (Tanner’s stage, TS). Body weight and height were
measured in each child, and the BMI z-score (the num-
ber of SD units that the child’s BMI deviates from the
mean reference value for age and gender) relative to
U.S. growth reference charts for 2000 [17], was calcu-
lated. The oral glucose tolerance test (OGTT) was per-
formed with a load of 1.75 g/kg/body weight of glucose
(maximum 75 gr) after a 12-hour overnight fast accord-
ing to the World Health Organization recommenda-
tions. Plasma glucose and insulin levels were measured
every 30 minutes for 120 minutes. The insulin value was
considered normal if < 5.91 μU/ml [18].
Insulin sensitivity was estimated by the Homeostasis
Model Assessment for Insulin Resistance (HOMA-IR)
index from fasting glucose and insulin concentrations
according to the following formula: insulin (mU/L) ×
glucose (mmol/L)/22.5 and referred to the normal
values of HOMA-IR for children and adolescents
assessed by d’Annunzio et al [19]. As the HOMA-IR
index has been found very low in prepubertal children
and increases with TS, we referred to the normal
HOMA-IR values for TS [19].
Alterations of glucose metabolism were defined,
according to the American Diabetes Association guide-
lines, as a fasting plasma glucose level between 100 and
126 mg per decilitre (impaired fasting glucose, IFG) and
a two-hour plasma glucose level of 140 to 200 mg per
decilitre (impaired glucose tolerance, IGT); type 2 dia-
betes was defined as a fasting glucose level of 126 mg/dl
or higher or a 2-h plasma glucose level of 200 mg/dl or
higher [20,21].
In all the patients enrolled, inflammatory bowel dis-
eases (IBD) and systemic or intestinal infections were
excluded during the evaluation.
CRP was the marker of systemic inflammation; it was
considered abnormal if >0.5 mg/dl.
Rectal nitric oxide (NO) was measured in all patients
by a dialysis bag, as described previously [22,23]. Briefly,
a dialysis bag (3 cm long) was placed into the rectum
and left for 30 min. The bag contained the following
isotonic electrolyte solution: 20 mM KCl, 30 mM
NaHCO3 and 110 mM NaCl. NO and its stable metabo-
lites NO2
- and NO3
- were measured by the Griess reac-
tion. Normal value was considered < 5 uM [23].
Faecal concentration of calprotectin was measured by
a commercially available enzyme-linked immunosorbent
assay (ELISA) test (Calprest Eurospital, SpA, Trieste,
Italy). Normal concentrations of faecal calprotectin for
adults range between 0 and 50 μg/g of wet stools, and
values greater than 50 μg/g indicate intestinal inflamma-
tion [24]. These cut off levels are used for children older
than 4 years [25] whereas the normal faecal concentra-
tion of calprotectin may be slightly higher in younger
children [25]. However, faecal calprotectin values con-
stantly higher than 100 μg/g are an alarm of intestinal
inflammation.
Statistical analysis
Statistical analysis was performed using SPSS software
(SPSS, Chicago, IL, USA). Results are expressed as
means ± SD or medians and range. Discrete values were
expressed as percentage. A p value of less than 0.05 was
considered significant. Linear correlation was used to
evaluate the significance of the association between sys-
temic and intestinal inflammation parameters and BMI
z-score. ANOVA test was used to compare groups.
Results
Thirty-four obese children (25 males and 9 females; med-
ian age 10.8 ± 3.4 yrs) were enrolled. Of the 25 boys, pub-
ertal development was TS II in 22 and TS III in 3. Of the
9 girls, 3 were TS II, 2 were TS III and 4 were TS IV.
The BMI was >95° pc, ranging from 23 to 44 kg/m
2 and
BMI z-score between 2.08 e 4.93, median 2.69 ± 0.53
(Table 1).
Table 1 Clinical features of 34 Severely Obese Children
(25 males and 9 females)
Overall
(n = 34)
NGT
(n = 10)
IGT
(n = 24)
DM 2
(n = 7)
Age (yrs) (mean ± SD) 10.8 ± 3.4 9.6 ± 2.8 10.2 ±
3.9
9.7 ± 3
BMI (Kg/m
2) (range) 23-44 25-40 23-44 23-42
BMI z-score (mean ±
SD)
2.69 ± 0.53 2.5 ±
0.33
2.8 ±
0.65
2.56 ± 0.6
BMI: body mass index; NGT: Normal Glucose Tolerance; IGT: Impaired Glucose
Tolerance; DM2: Diabetes Mellitus Type 2; SD: standard deviation.
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(71%) patients. In particular type 2 diabetes was observed
in 7/24 patients (29%); impaired fasting glucose (IFG) in
14/24 patients (58%), impaired glucose tolerance (IGT) in
9/24 patients (37.5%). Six patients (25%) presented IFG
and IGT. In 10/34 children (29%) there were no abnorm-
alities of glucose metabolism (Figure 1, 2).
There was no difference in the prevalence of altera-
tions of glucose metabolism in males and females and
no alterations with respect to TS.
Hyperinsulinism and Insulin resistance
Thirty-one patients (91%) were hyperinsulinemic (Figure 1).
Mean insulinemia was 30.35 ± 38.7 μU/ml. It was
pathological in 22/24 (92%) patients with glucose abnorm-
alities, mean 36.36 ± 43.03 μU/ml, and in particular in 7/7
diabetic patients (100%).
A total of 30/34 patients (88.2%) had insulin resis-
tance, defined by values compared with HOMA-IR
index in healthy Italian children and adolescents,
grouped by sex and TS [19]. The mean value of insulin
resistance was 4.02 ± 5.8 for males TS II-III; 5.4 ± 8.2
for girls TS II-III; 7.9 ± 10.1 for girls TS IV. Values of
HOMA-IR index were significantly higher in girls TS IV
compared to males TS II-III and females TS II-III (p <
0.05). HOMA-IR index was abnormal in 22/24 (92%)
patients with glucose abnormalities, mean 9.7 ± 12, and
in all the diabetic patients.
Figure 1 Obese children with and without glucose abnormalities (n = 34). a: 71% with glucose abnormalities; 91% with hyperinsulinism b:
Obese children with glucose abnormalities n = 24. 29% diabetes type 2; 58% impaired fasting glucose IFG; 37,5% impaired glucose tolerance
IGT; 25% IFG/IGT.
Figure 2 Blood glucose levels during OGTT in obese children. Mean (± SD) Plasma Glucose (mg/dl) during the Oral Glucose-Tolerance Test
in obese children with Type 2 Diabetes Melitus, Impaired Glucose Tolerance or Normal Glucose Tolerance.
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CRP
CRP was increased in 25/34 (73.5%) obese patients, in
particular in 5/7 (71%) with diabetes (mean 1.1 ± 0.53
mg/dl), indicating a low degree of systemic inflamma-
tion. Moreover, a statistical significant correlation was
detected between BMI z-score and CRP >0.5 (p 0.03)
(Figure 3).
Faecal calprotectin
Faecal calprotectin was increased in 16/34 obese chil-
dren (47%). It ranged from 15 to 270 μg/g with a mean
value of 77 ± 68 μg/g, indicating a mild increase over
normal. Individual values exceeded 100 μg/g in 12
patients (35%). Moreover, a significant correlation was
detected between calprotectin and worsening obesity
(BMI z-score) (Figure 3).
Rectal Nitric Oxide
Median rectal nitric oxide was 6.8 ± 5 μM. It was patholo-
gical in 30/34 obese children (88%), in particular in 21/24
patients with alteration of glucose metabolism (87.5%,
mean 6.5 ± 5), and in 7/7 diabetics (mean 8.9 ± 5.3).
Discussion
T h ef r e q u e n c yo fg l u c o s ea b n ormalities in our studied
obese paediatric population is higher than other
reported data. These abnormalities increase with wor-
sening obesity.
Sinha et al described a prevalence of impaired glucose
tolerance in 25% of obese children and 21% of obese ado-
lescents and identified silent type 2 diabetes in 4% of this
population [20]. Wiegand et al. found that 36.3% of Cauca-
sian children and adolescents with obesity had impaired
glucose tolerance and 5.9% type 2 diabetes [26]. In the pre-
sent study we recruited very severely obese children and
adolescents and the prevalence of hyperinsulinism,
impaired glucose tolerance and diabetes type 2 appears
largely higher than that described, being respectively 91%,
70.5% and 20.5%. In our opinion, this could be due to the
higher risk characteristics of the studied population.
The vigorous hyperinsulinemic response to glucose
found in the prediabetic stage in obese children and ado-
lescents may reflect an up-regulation of beta-cell function
caused by chronic severe insulin resistance [20]. Such a
degree of hyperinsulinemia is not present in adults with
impaired glucose tolerance [27,28]. The observation of
hyperinsulinism in 92% of our patients with IGT confirm
that insulin resistance is a strong predictor of the two-
hour plasma glucose levels in youngsters, and the pre-
sence of high insulin levels in 100% of diabetics shows
that beta-cell function was still preserved.
Alterations of glucose metabolism are related with
markers of systemic and intestinal inflammation [29]. In
this study an increased CRP (mean 1 ± 0.5) was present
in more than 2/3 of patients with glucose abnormalities
and in particular in 71% of diabetics (p < 0.05). We
found a significant correlation between BMI z-score and
CRP >0.5 (p 0.03), documenting a low grade systemic
inflammation that increases with BMI in obese children.
Similarly, faecal calprotectin is elevated in obese adults
and a correlation between CRP and calprotectin levels in
this population is already described [6]. In our data, one
third of children showed calprotectin concentrations
above 100 μg/g and in 2 cases of very severe obesity the
values were above 200 μg/g, almost reaching the levels
measured in children with IBD [22]. We consider that
these results, in the absence of specific intestinal symp-
toms and of intestinal diseases, and on the basis of faecal
calprotectin and CRP levels intermediate between a nor-
mal intestinal mucosa and an active inflammation as an
IBD, are an important evidence of chronic gut inflamma-
tion due to obesity also if on a small number of children.
To our knowledge, the significance shown between BMI-
z score and CRP and faecal calprotectin represents the
first evidence of increased gut inflammatory activity in
Figure 3 Linear correlation between BMI z-score and CRP and faecal calprotectin in 34 severely obese children.
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worsening intestinal inflammation with the grade of
obesity.
Our data on rectal NO production support the calpro-
tectin results. It has been reported that rectal NO pro-
duction increases during active inflammation in children
with IBD [22,23]. In this series, we found abnormal
values of rectal NO in 88% of patients, in particular in
87.5% of those with glucose abnormalities and in 100%
of diabetics. The increase in NO production in our chil-
dren support the hypothesis that intestinal inflammation
is a major feature in severe obesity and implicates the
distal intestine in this process.
Findings in adult humans and in animals suggest that
the inflammatory status at mucosal surfaces of various
organs as adipose tissue, oesophagus, pancreas, colon
[6,7], associated with the increase of fat mass, may be
involved in the pathogenetic pathways of obesity
complications.
In 2006 Sbarbati identified in a group of obese chil-
dren, by ultramicroscopic analysis, the elementary
“inflammatory” lesion of the adipose tissue consisting in
a microgranuloma that evolves to fibrosis [30]. The
lesion was not found in non-obese children and the
extent of the lesion seemed to depend on the SD score
of body mass index, proving that an “inflammatory” pro-
cess exists in the adipose tissue of obese children and
that it is an early alteration in humans [30]. Data
regarding the histological lesion of the inflamed intest-
inal mucosa of obese children are lacking at the
moment, but a similar pathway can be hypothesized.
The evidence of inflammatory involvement of the distal
intestine of obese children suggests an early onset of
pathogenetic mechanisms that may lead to the compli-
cations of obesity as GI cancers. In this view, rectal NO
and faecal calprotectin are useful non-invasive, reprodu-
cible and non-discomfortable tests to indirectly evaluate
the intestinal status of severely obese children. Anyway,
further research in this field is warranted.
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